October 27, 2009; 73 (17) Correspondence
HEPATITIS B VACCINE AND THE RISK OF CNS INFLAMMATORY DEMYELINATION IN CHILDHOOD
M. Lièvre, Members of the Epidemiology Working Group of the French Pharmacovigilance Commission, D. Costagliola, S. Evans, A. Fourrier, J. -L. Imbs, D. Levy-Bruhl, L. Merle, J. Micallef, E. Oger
First published October 26, 2009, DOI: https://doi.org/10.1212/WNL.0b013e3181bd1f7e
M. Lièvre
D. Costagliola
S. Evans
A. Fourrier
J. -L. Imbs
D. Levy-Bruhl
L. Merle
J. Micallef
HEPATITIS B VACCINE AND THE RISK OF CNS INFLAMMATORY DEMYELINATION IN CHILDHOOD
M. Lièvre, Members of the Epidemiology Working Group of the French Pharmacovigilance Commission, D. Costagliola, S. Evans, A. Fourrier, J. -L. Imbs, D. Levy-Bruhl, L. Merle, J. Micallef, E. Oger
Neurology Oct 2009, 73 (17) 1426-1427; DOI: 10.1212/WNL.0b013e3181bd1f7e
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 73 no. 17 1426-1427
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published October 26, 2009.
Copyright & Usage:
© 2009
Author Disclosures
- M. Lièvre,
- Members of the Epidemiology Working Group of the French Pharmacovigilance Commission,
- D. Costagliola,
- S. Evans,
- A. Fourrier,
- J. -L. Imbs,
- D. Levy-Bruhl,
- L. Merle,
- J. Micallef and
- E. Oger
- M. Lièvre,
- Members of the Epidemiology Working Group of the French Pharmacovigilance Commission,
- D. Costagliola,
- S. Evans,
- A. Fourrier,
- J. -L. Imbs,
- D. Levy-Bruhl,
- L. Merle,
- J. Micallef and
- E. Oger
Article usage
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Special Article
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of NeurologyMauricio F. Farez, Jorge Correale, Melissa J. Armstrong et al.Neurology, August 28, 2019 -
Articles
Recombinant hepatitis B vaccine and the risk of multiple sclerosisA prospective studyMiguel A. Hernán, Susan S. Jick, Michael J. Olek et al.Neurology, September 13, 2004 -
Editorials
Hepatitis vaccines and pediatric multiple sclerosisDoes timing or type matter?Jayne M. Ness, James F. Bale, Jr et al.Neurology, December 17, 2008 -
Articles
Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhoodYann Mikaeloff, Guillaume Caridade, Samy Suissa et al.Neurology, October 08, 2008